Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) — The “Cancer Monoclonal Antibodies Market by Antibody Type, Medication Type, Application, End-User, and Region 2025-2033” report has been added to ResearchAndMarkets.com’s offering.
The global cancer monoclonal antibodies market size reached USD 48.3 Billion in 2024. Looking forward, the market is forecast to reach USD 65.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.4% during 2025-2033.
The increasing prevalence of cancer across the globe is one of the key factors driving the growth of the market. In comparison to traditionally used non-targeted therapies, such as chemotherapy, monoclonal antibodies have reduced side-effects on the patient’s body and can also be used for the treatment of autoimmune and inflammatory diseases. Furthermore, widespread adoption of cost-efficient biosimilar monoclonal antibodies by medical practitioners and oncologists is also providing a boost to the market growth.
With technological advancements in gene sequencing and target gene selection, these antibodies can be modified to have similar properties to that of a pharmaceutical drug. They have the same efficiency but are available at reduced prices than the original medicine, which aids in enhancing the cost-efficiency of the treatment, thereby contributing to the increasing demand for the product across the globe.
Other factors, including rising preference for personalized medicines, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, are projected to drive the market further.
Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global cancer monoclonal antibodies market report, along with forecasts at the global, regional and country level from 2025-2033. The report has categorized the market based on antibody type, medication type, end-user and application.
Breakup by Antibody Type
- Murine Antibodies
- Chimeric Antibodies
- Humanized Antibodies
- Others
Breakup by Medication Type
- Bevacizumab (Avastin)
- Rituximab (Rituxan)
- Trastuzumab (Herceptin)
- Cetuximab (Erbitux)
- Panitumumab (Vectibix)
- Others
Breakup by Application
- Breast Cancer
- Blood Cancer
- Liver Cancer
- Brain Cancer
- Colorectal Cancer
- Others
Breakup by End-User
- Hospitals and Clinics
- Pharmacies
- Research Laboratories
- Others
Breakup by Region
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined with some of the key players being:
- AbbVie Inc.
- Amgen Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Genmab A/S
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Roche Holding AG
- Seattle Genetics Inc.
- Spectrum Pharmaceuticals Inc.
Key Questions Answered in This Report
- How has the global cancer monoclonal antibodies market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global cancer monoclonal antibodies market?
- What is the breakup of the market based on the antibody type?
- What is the breakup of the market based on the medication type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global cancer monoclonal antibodies market and who are the key players?
- What is the degree of competition in the industry?
Key Attributes
| Report Attribute | Details |
| No. of Pages | 144 |
| Forecast Period | 2024-2033 |
| Estimated Market Value (USD) in 2024 | $48.3 Billion |
| Forecasted Market Value (USD) by 2033 | $65.5 Billion |
| Compound Annual Growth Rate | 3.4% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/d35qud
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Cancer Monoclonal Antibodies Market
